In prostate tissue, the deletion of Scrib promotes tumorigenesis by activation of the pro-proliferative MAPK pathway (Pearson et al., 2011), while it promotes Myc-dependent breast tumor initiation by reducing myc-induced apoptosis (Zhan et al., 2008). Here, MYC is linked to breast neoplasm.